AquaPass

Fluid Overload Treatment Solution

Health Tech & Life Sciences
Active
Seed Tel Aviv-Yafo, Israel Founded 2019
Last updated 2026-06-18
Total raised
Last: Undisclosed Round 2022-01
Stage
Seed
Founded
2019
Headcount
15
HQ
Tel Aviv-Yafo, Israel
Sector
Health Tech & Life Sciences

About

AquaPass is an early-stage medical device startup aiming to revolutionize the treatment of fluid overload. Its noninvasive, drug-free fluid overload treatment system removes fluids directly from the interstitial compartment through the skin by controlling and enhancing the natural process of perspiration.

The company’s award-winning, patented system is composed of a wearable body suit with a microclimate generator designed to create the optimal environmental conditions to induce both natural perspiration and its immediate evaporation, ensuring that the patient remains dry and free of thermal discomfort.

The AquaPass system maintains a stable core temperature while enabling treatment to be optimized according to each patient’s individual physiology. This highly efficient and safe treatment can be provided in the hospital, at outpatient clinics, and at home.

Funding history · 2 rounds · — total

2021-12
Seed Undisclosed
★ Arbelon Holdings Ltd
2019-06
Pre-Seed Undisclosed
★ BRM Group

Headcount over time

From 31 (2022-10) to 22 (2026-03) · -9 (-29%) · 15 points · source: Finder history + radar grounding
310 2022-10 2026-03

Q&A

What is AquaPass's primary focus?
AquaPass is an early-stage medical device startup focused on revolutionizing the treatment of fluid overload with a noninvasive, drug-free system.
How does the AquaPass system work?
The AquaPass system is a wearable body suit with a microclimate generator designed to induce natural perspiration and immediate evaporation, removing fluids directly from the interstitial compartment through the skin.
When was AquaPass founded?
AquaPass was founded in July 2019.
Which investors have participated in AquaPass's funding rounds?
AquaPass has received funding from BRM Group and Arbelon Holdings Ltd.
What is the latest funding round date for AquaPass?
The latest funding round for AquaPass occurred in January 2022.
What is AquaPass's current product stage?
AquaPass's product is currently in the clinical trial stage.
Does AquaPass hold any patents?
Yes, AquaPass holds patents for its technology.
Who is the Founder & CTO of AquaPass?
Yaacov Nitzan is the Founder & CTO of AquaPass.

Team · 1

Founder · Founder & CTO
LinkedIn ↗

Sectors & technology

Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesMedical DevicesMedical Treatment & Therapeutics
Target customers
Healthcare & Life SciencesHealthcarePatientsProviders
Business model
B2B

Highlights

1 Patents

Tags

wearablewearabletreatmentsmedical-devices
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)

External links

Websiteaquapass-medical.com/
LinkedInlinkedin.com/company/86694349
YouTubeyoutube.com/channel/UCEpfo6G8wGxbVdJq4rXaQVw

Identifiers & details

Founded2019-7
Employees (exact)15

Radar intelligence

Patents

EPO6

Publications (Crossref)

Works4

Web history (Wayback)

Domainaquapass-medical.com

Certificate / subdomain footprint

Subdomains2

Israeli Companies Registrar (רשם החברות / ICA)

Registrar # (ח.פ.)516057684
Statusפעילה
Corp typeישראלית חברה פרטית
Incorporated2019-07-18
Purposeלעסוק בכל עיסוק חוקי
Liabilityמוגבלת
In violation (unfiled)no
Last annual report2025
Active charges / liens0
Registry events5 — charge (3), shares_capital (2)
Registered address0 שפיים

Recent registry events

DateEvent
2025-12-24רישום שעבוד
2025-11-10סילוק שעבוד
2025-11-10סילוק שעבוד
2025-11-03הקצאת מניות
2025-11-03העברת מניות